Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease ; volume:2 ; number:1 ; day:21 ; month:10 ; year:2014 ; pages:1-14 ; date:12.2014
Acta Neuropathologica Communications ; 2, Heft 1 (21.10.2014), 1-14, 12.2014

Creator: Tai, Hwan-Ching

Contributor: Wang, Bo Y.
Serrano–Pozo, Alberto
Frosch, Matthew P.
Spires-Jones, Tara L.
Hyman, Bradley T.
SpringerLink (Online service)

DOI: 10.1186/s40478-014-0146-2

URN: urn:nbn:de:1111-201605067260

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tai, Hwan-Ching
Wang, Bo Y.
Serrano–Pozo, Alberto
Frosch, Matthew P.
Spires-Jones, Tara L.
Hyman, Bradley T.
SpringerLink (Online service)

Other Objects (12)

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Hochschulschrift

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Hochschulschrift

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Hochschulschrift

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Hochschulschrift

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease

Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease

Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease

Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease

Related objects

Reset password